Gear Up With Summer-Ready Watches Built For Everyday Toughness

Gear up for summer with watches that are built for everyday toughness. These timepieces are designed to withstand the elements and keep up with an active lifestyle.

Concentrix Strengthens Employee Security And Well-Being Through Comprehensive Benefits

Concentrix is dedicated to enhancing employee security and well-being through a wide range of comprehensive benefits.

Vivant Water 20 MLD Desalination Plant Partners With MCWD For Water Supply In Metro Cebu

Vivant Water has entered into a significant partnership with the Metropolitan Cebu Water District to secure water supply for Metro Cebu.

Balik Probinsya Tips: 4 Ways To Maximize Your Out Of Town Trip

Summer is here, and many are heading to their hometowns for family reunions or a much-needed break. Here are ways to enhance the experience.

Global Coronavirus Cases Surpass 40M

The number of the COVID-19 cases in the world has surpassed 40 million on Monday.

Global Coronavirus Cases Surpass 40M

21
21

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The number of the coronavirus disease 2019 (Covid-19) cases in the world has surpassed 40 million early Monday, according to Johns Hopkins University data.

More than 1.11 million people have lost their lives around the world from Covid-19 so far.

The US still leads the world in the number of Covid-19 cases with over 8.15 million, while deaths are at almost 220,000.

In India, more than 7.55 million people contracted the virus with a death toll of over 114,600. Brazil has more than 5.22 million cases and a death toll exceeding 153,600.

China, the birthplace of Covid-19, has close to 91,000 cases with 4,739 deaths.

The UK’s Scientific Advisory Group for Emergencies said Sunday more than one coronavirus vaccine will be available at the beginning of 2021.

American pharmaceutical firm Pfizer said Friday it may know the effectiveness of its vaccine by the end of October, and it is planning to submit safety data on the final dose of the vaccine to the US Food and Drug Administration in the third week of November.

A vaccine candidate developed by the Beijing Institute of Biological Products, affiliated to the state-owned China National Pharmaceutical Group (Sinopharm), elicited antibody response in recipients, according to a study published Thursday in the Lancet Infectious Diseases journal.

Meanwhile, Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine, EpiVakKorona, has been granted regulatory approval.

There are more than 170 vaccines around the world that are candidates for Covid-19 and tracked by the World Health Organization, but none has been approved for general use yet. (PNA)